Yue, Tao
Zhao, Da https://orcid.org/0000-0002-8292-5036
Phan, Duc T. T.
Wang, Xiaolin
Park, Joshua Jonghyun
Biviji, Zayn
Hughes, Christopher C. W.
Lee, Abraham P.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UG3 HL141799-02)
U.S. Department of Health & Human Services | National Institutes of Health (UG3 HL141799-02)
National Science Foundation (CADMIM)
National Natural Science Foundation of China (61803250)
National Natural Science Foundation of China (31600781)
Shanghai Science and Technology Development Foundation (19QA1403700)
Shanghai Science and Technology Development Foundation (17JC1400202)
Shanghai Science and Technology Development Foundation (19ZR1475000)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 18 June 2020
Revised: 19 October 2020
Accepted: 17 November 2020
First Online: 6 January 2021
Conflict of interest
: A.P.L. and C.C.W.H. are co-founders of Aracari Biosciences Inc., which is commercializing vascularized micro-organ technology. D.T.T.P. serves as scientific consultant and receives stock and financial compensation from Aracari Biosciences Inc.